| 体内研究: |
The maximum tolerated dose of TMX-201 by i.v. administration is 75 mg/kg. TMX-201 (4mg/kg, IP) suppresses the growth of established subcutaneous B16 melanoma by 46%, without discernible adverse effects. TMX-201 (IP or intra-tumor administration), in combination with anti-CTLA4 antibody, significantly suppressed lung metastasis formation in the 4T1 breast cancer model. |
| 参考文献: |
1. Dennis A. Carson, et al. Application of novel phospholipid conjugated Toll like receptor 7 ligands for cancer therapy by topical and systemic administration. Cancer Res 2014;74(19 Suppl): 2568. |
| 保存条件: |
-80℃,避光,干燥(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0.921 ml |
4.607 ml |
9.214 ml |
| 5 mM |
0.184 ml |
0.921 ml |
1.843 ml |
| 10 mM |
0.092 ml |
0.461 ml |
0.921 ml |
| 50 mM |
0.018 ml |
0.092 ml |
0.184 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |